Literature DB >> 10545829

The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis.

E H Choi1, S H Lee, S K Ahn, S M Hwang.   

Abstract

The transdermal drug delivery (TDD) system has largely been divided into physical, biochemical and chemical methods. Recently, combinations of these methods were introduced for more effective delivery with less side effects. We performed this study to identify the effectiveness and mechanism of TDD using the physical method, 'iontophoresis', plus the chemical method, 'pretreatment with chemical enhancer'. The action sites of chemical enhancers in the stratum corneum (SC) were observed by electron microscope. We also studied whether this combined method synergistically impaired the skin barrier. To confirm the synergistic effect on skin penetration by this combined method, we measured the blood glucose level after insulin iontophoresis following a chemical enhancer pretreatment in rabbits. The results were that (1) dilatation of the intercellular lipid layers of the SC and lacunae was prominent in pretreatment with chemical enhancers inducing high transepidermal water loss (TEWL); (2) the skin barrier impairment, with repeated treatments showing an increased TEWL and also epidermal proliferation, was increased with the chemical enhancers that showed a high TEWL immediately after treatment; (3) the combination of chemical enhancer pretreatment and iontophoresis showed no synergistic impairment of the skin barrier, and (4) the chemical enhancer pretreatment with greater impairment of the skin barrier could increase the delivery of insulin by iontophoresis. The results showed that a combination of chemical enhancer pretreatment and iontophoresis could deliver drugs more effectively than iontophoresis alone. Our proposed theory is that iontophoretic drug delivery may be easier through the dilated intercellular spaces of the SC which have a lower electrical impedance following the chemical enhancer pretreatment. Because the effect and the side effects in the combination are decided by the chemical enhancer rather than iontophoresis, the development of proper chemical enhancers is important in future plans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545829     DOI: 10.1159/000029894

Source DB:  PubMed          Journal:  Skin Pharmacol Appl Skin Physiol        ISSN: 1422-2868


  9 in total

Review 1.  Synergistic effect of enhancers for transdermal drug delivery.

Authors:  S Mitragotri
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro.

Authors:  G L Li; M Danhof; J A Bouwstra
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 3.  The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.

Authors:  N K Brogden; L Mehalick; C L Fischer; P W Wertz; K A Brogden
Journal:  Skin Pharmacol Physiol       Date:  2012-04-26       Impact factor: 3.479

4.  Permeation of topically applied caffeine through human skin--a comparison of in vivo and in vitro data.

Authors:  Sindy Trauer; Alexa Patzelt; Nina Otberg; Fanny Knorr; Christel Rozycki; Gabor Balizs; Rolf Büttemeyer; Michael Linscheid; Manfred Liebsch; Jürgen Lademann
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

Review 5.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

6.  A skin permeability model of insulin in the presence of chemical penetration enhancer.

Authors:  K M Yerramsetty; B J Neely; S V Madihally; K A M Gasem
Journal:  Int J Pharm       Date:  2009-12-21       Impact factor: 5.875

Review 7.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

8.  Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro.

Authors:  Gai Ling Li; Meindert Danhof; Peter M Frederik; Joke A Bouwstra
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

9.  Effects of fatty acids and iontophoresis on the delivery of midodrine hydrochloride and the structure of human skin.

Authors:  Yiping Wang; Qiuxi Fan; Yifan Song; Bozena Michniak
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.